Probiotics in infective diarrhoea and inflammatory bowel diseases.
about
Probiotics and medical nutrition therapyBifidobacteria and Their Role as Members of the Human Gut MicrobiotaMechanisms of Natural Tolerance in the IntestineProbiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanismEubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity.Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cellsThe emerging role of leptin antagonist as potential therapeutic option for inflammatory bowel disease.Synergistic protection of combined probiotic conditioned media against neonatal necrotizing enterocolitis-like intestinal injury.Carbohydrates: a limit on bacterial diversity within the colon.Plasmacytoid dendritic cells are crucial in Bifidobacterium adolescentis-mediated inhibition of Yersinia enterocolitica infectionLactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contractionIdentification of commensal bacterial strains that modulate Yersinia enterocolitica and dextran sodium sulfate-induced inflammatory responses: implications for the development of probiotics.Probiotics and their fermented food products are beneficial for health.Probiotic properties of lactic acid bacteria isolated from traditionally fermented Xinjiang cheese.The probiotic Lactobacillus acidophilus stimulates chloride/hydroxyl exchange activity in human intestinal epithelial cells.Neonatal Necrotizing Enterocolitis -Inflammation and Intestinal Immaturity.Do probiotics offer opportunities to manipulate the periodontal oral microbiota?A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics.A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients.Differential effect on cell-mediated immunity in human volunteers after intake of different lactobacilli.Antinociceptive effect of VSL#3 on visceral hypersensitivity in a rat model of irritable bowel syndrome: a possible action through nitric oxide pathway and enhance barrier function.Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial.Protective effects of Lactobacillus rhamnosus [corrected] and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve.Analysis of caecal microbiota in rats fed with genetically modified rice by real-time quantitative PCR.Microorganisms and calcium oxalate stone disease
P2860
Q24548441-FE027E54-6BBE-4F38-B090-EDCAC28F5A8AQ26744578-B7819354-6ADC-4527-9D32-7AE8C236752DQ29031968-0F43A1FA-14CE-42DF-941A-E46768B3E760Q30425823-D138FDF0-D3AD-4A82-9872-4CB20BD59BC4Q33868123-C559D652-9F9D-4DE9-A740-56F61635461CQ34013041-B4AC9858-DBA0-41E1-9F71-C43161A4E645Q34157927-985900C5-90D9-4156-A59E-7E0900DDB855Q34746651-55D3D9B2-A87B-4109-BA2B-E575C2EBF78CQ34846603-33467C51-27A5-46FF-B029-435072DD1AF3Q34970905-111BDB87-00E9-4EE6-AB60-6138F50E3014Q35760577-387FCFEF-1327-4094-B525-B7C43E3BC5A0Q35913648-CB7EBB38-B7D5-41F2-9D5F-3296A3FD7E92Q36476720-DC8D4F0D-7AEB-41D4-91B6-7AF23F57F2C0Q37166119-BD260923-9D52-4703-B920-6AA71D027321Q37248829-506364DF-65CF-4F6D-9BC4-1C1999DAFB5DQ37760432-B13EDFE2-CAD2-4075-8999-2D7C0B2CEF6DQ37842653-18DB2166-BDCF-45CA-B1DC-6DFD1C520693Q37994645-BCDAAA8A-E052-495D-84CC-126666F505C2Q38143713-5E2AEA39-575A-4037-852B-72147276574BQ40225216-379A8935-4F97-4CF7-9EF6-990EC3381162Q42267314-4C1F0EDC-7D6C-4073-8E17-DA9315078F4BQ43335495-00C02733-DFCD-4AFB-BAC6-D8D3EBF2EF4AQ44305775-6CEA5588-EFC3-4325-81D6-0808AA4622E9Q49024396-EE05A2A7-9467-41C6-9B39-A8FE0FFC988EQ50521533-608BAA18-0317-47FC-B9B8-1D09E2DDFEB7Q57222745-457133FD-3D8A-4F3A-8AED-5979F0404BC4
P2860
Probiotics in infective diarrhoea and inflammatory bowel diseases.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Probiotics in infective diarrhoea and inflammatory bowel diseases.
@ast
Probiotics in infective diarrhoea and inflammatory bowel diseases.
@en
type
label
Probiotics in infective diarrhoea and inflammatory bowel diseases.
@ast
Probiotics in infective diarrhoea and inflammatory bowel diseases.
@en
prefLabel
Probiotics in infective diarrhoea and inflammatory bowel diseases.
@ast
Probiotics in infective diarrhoea and inflammatory bowel diseases.
@en
P2860
P50
P921
P1476
Probiotics in infective diarrhoea and inflammatory bowel diseases
@en
P2093
P2860
P304
P356
10.1046/J.1440-1746.2000.02162.X
P577
2000-05-01T00:00:00Z